Co-administration of cyclosporin enables oral therapy with paclitaxel

Lancet. 1998 Jul 25;352(9124):285. doi: 10.1016/s0140-6736(98)24030-x.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors
  • Administration, Oral
  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Biological Availability
  • Cyclosporine / administration & dosage*
  • Drug Therapy, Combination
  • Humans
  • Infusions, Intravenous
  • Mice
  • Mice, Knockout
  • Neoplasms / drug therapy
  • Paclitaxel / administration & dosage*
  • Paclitaxel / pharmacokinetics

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antineoplastic Agents, Phytogenic
  • Cyclosporine
  • Paclitaxel